The purpose of this study is to investigate the treatment of pancreatic adenocarcinoma, cholangiocarcinoma, lung cancer, gastric cancer, esophageal carcinoma, or breast cancer that are resistant to Taxanes.
This study evaluates the safety and effectiveness of an investigational medication for these types of cancer.
- Who can participate: Adults 18 years and older with specific advanced cancers resistant to Taxanes may participate. Participants must have an evaluable lesion and meet certain health criteria.
- Study details: Participants will receive an investigational medication. The study will monitor the effects and any side effects. An inactive substance called a placebo will not be used in this study.